Why is Zim Laboratories falling/rising?

As of 30-Jun, Zim Laboratories Ltd's stock price is currently at 111.87, reflecting an increase of 0.97 or 0.87%. The stock has shown a trend reversal by gaining after four consecutive days of decline. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive short-term momentum. However, the stock's performance over the past week has been negative at -0.81%, while it has seen a significant increase of 25.34% over the past month. Despite this recent uptick, the company has faced challenges, including a -29.5% decline in profits over the past year, and it has reported negative results for the last four consecutive quarters, which may contribute to investor caution.
In the broader market context, the Sensex has outperformed Zim Laboratories in the short term, gaining 2.09% over the past week and 2.65% over the past month. This suggests that while Zim Laboratories is experiencing a slight recovery, it is lagging behind the overall market performance. Additionally, the company's low domestic mutual fund ownership, at 0%, may indicate a lack of confidence among institutional investors, further impacting its stock price. The combination of attractive valuation metrics and poor long-term growth prospects, alongside declining investor participation, paints a complex picture for the stock's future trajectory.